Nov. 27, 2012
/PRNewswire/ -- The Female Health Company (NASDAQ-CM: FHCO) today announced that it will host an investor conference call to discuss its operating results for the quarter and fiscal year ended
September 30, 2012
Tuesday, December 4, 2012
11:00 a.m. Eastern Time
(EST). The Company expects to report its operating results earlier the same day.
Shareholders and other interested parties may participate in the conference call by dialing 1-877-374-8416 (international participants dial 1-412-317-6716) and asking to be connected to "The Female Health Company Conference Call" a few minutes before 11:00 a.m. EST on December 4, 2012. A replay of the call will be available one hour after the call through 9:00 a.m. EST on Tuesday, December 18, 2012 by dialing 877-344-7529 (international callers dial 412-317-0088) and entering the conference ID 10021755.
About The Female Health Company
The Female Health Company, based in
, manufactures and markets
the FC2 Female Condom® (FC2),
which is available in the U.S. and approximately 138 other countries globally. The Company owns certain worldwide rights to the
FC2 Female Condom®,
including patents that have been issued by the U.S., the European
The People's Republic of China
and the African Regional Intellectual Property Organization (ARIPO), which includes
, United Republic of
patent applications are pending in various countries. The
FC2 Female Condom®
is the only available FDA-approved product controlled by a woman that offers dual protection against sexually transmitted diseases, including HIV/AIDS, and unintended pregnancy. The World Health Organization (WHO) has cleared
for purchase by U.N. agencies.